Fulgent Genetics, Inc. (FLGT) › Shareholders' EquityFulgent Genetics, Inc. (FLGT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: $1.97M2014: $1.68M2015: $5.15M2016: $54.48M2017: $54.18M2018: $51.15M2019: $82.78M2020: $569.39M2021: $1.16B2022: $1.27B2023: $1.14B2024: $1.13B2025: $1.11B$1.11B2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.11B-1.9%2024$1.13B-0.3%2023$1.14B-10.3%2022$1.27B+9.3%2021$1.16B+103.5%2020$569.39M+587.9%2019$82.78M+61.8%2018$51.15M-5.6%2017$54.18M-0.6%2016$54.48M+958.7%2015$5.15M+205.6%2014$1.68M-14.4%2013$1.97M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share